Skip to main navigation menu Skip to main content Skip to site footer

Gingivostomatitis in pediatric patients with SARS-CoV-2 infection

Gingivoestomatitis en paciente pediátrico con infección por SARS-CoV-2.




Section
Case Reports

How to Cite
Lázaro Mayoriano, Y., Beltrán Ricardo, E. ., & Vargas Rodriguez, L. J. . . (2024). Gingivostomatitis in pediatric patients with SARS-CoV-2 infection. Journal of Medicine and Surgery Repertoire, 33(1), 101-104. https://doi.org/10.31260/RepertMedCir.01217372.1443

Dimensions
PlumX
license

   


Yaquelin Lázaro Mayoriano,

Medico general, Hospital Internacional de Colombia, Piedecuesta, Santander, Colombia


Evaristo Beltrán Ricardo,

Medico general, Hospital Internacional de Colombia, Piedecuesta, Santander, Colombia


Ledmar Jovanny Vargas Rodriguez,

Medico epidemiólogo, Hospitales San Rafael de Tunja y Regional de la Orinoquia, Yopal, Colombia


Introduction: in SARS-CoV-2 infection, clinical otorhinolaryngologic and maxillofacial manifestations are the least frequent. The most reported include ulcerative lesions, vesicles, enanthema, gingival involvement and even acute otitis media, conjunctivitis, and parotiditis. Case presentation: a 33-months-old male patient, with no relevant history who was brought to the clinic for presenting with fever, cough, and odynophagia. Physical examination revealed hyperthermia, conjunctival hyperemia, oral aphthous ulcers and gingival bleeding. Diagnostic workup evidenced hypochromic microcytic anemia, normal coagulation times, slightly elevated LDH and positive RT-PCR test for SARS-CoV-2. He was hospitalized and monitored for 4 days, with adequate progression and subsequent discharge. Discussion: otorhinolaryngologic and maxillofacial manifestations are the least frequent, however, it has been evidenced that they can generate multiple compromises within this system, however, so far, no cases of COVID-19-related gingivostomatitis have been reported. Conclusions: oral manifestations can be considered atypical symptoms, since other pathological possibilities that could generate such symptomatology were ruled out.


Article visits 159 | PDF visits 153


Downloads

Download data is not yet available.
  1. Tezer H, Bedir Demirdağ T. Novel coronavirus disease (COVID-19) in children. Turk J Med Sci. 2020;50(SI-1):592-603. https://doi:10.3906/sag-2004-174.
  2. Chen ZM, Fu JF, Shu Q, Chen YH, Hua ChZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020;16:240-246. https://doi.org/10.1007/s12519-020-00345-5.
  3. Márquez-Aguirre MP, Gutiérrez-Hernández A, Lizárraga-López SL, Muñoz-Ramírez CM, Ventura-Gómez ST, Zárate-Castañón PMS, et al. Espectro clínico de COVID-19, enfermedad en el paciente pediátrico. Acta Pediatr Méx. 2020;41(Supl 1):S64-S71.
  4. Wu P, Liang L, Chen C, Nie S. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis. Graefes Arch Clin Exp Ophthalmol. 2020;258(7):1565-1566. https://doi:10.1007/s00417-020-04708-6.
  5. Zahran M, Ghazy R, Ahmed O, Youssef A. Atypical otolaryngologic manifestations of COVID-19: a review. Egypt J Otolaryngol. 2021;37(5). https://doi.org/10.1186/s43163-021-00075-z.
  6. Abobaker A, Raba AA, Alzwi A. Extrapulmonary and atypical clinical presentations of COVID-19. J Med Virol. 2020;92(11):24582464.https://doi:10.1002/jmv.26157.
  7. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID 19 Among Children in China. Pediatrics. 2020;145(6) e20200702. https://doi.org/10.1542/peds.2020-0702.
  8. Adeyinka A, Bailey K, Pierre L, Kondamudi N. COVID 19 infection: Pediatric perspectives. J Am Coll Emerg Physicians Open. 2021;2(1):e12375. https://doi:10.1002/emp2.12375.
  9. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, Rovida F, Baldanti F, Marseglia GL. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020;174(9):882889. https://doi:10.1001/jamapediatrics.2020.1467
  10. Amorim J, Normando AGC, Carvalho RL, Monteiro R, Cembranel AC, Santos AR, Silva EN. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? Int J Infect Dis. 2020;97:326-328. https://doi:10.1016/j.ijid.2020.06.012
  11. Gutiérrez R, Zambrano G. Implicaciones bucales por COVID-19. Revisión de tema. Odontol Sanmarquina. 2020;23(4):419-23.https://doi.org/10.15381/os.v23i4.19104
  12. Nemeth ME, Matus C, Carrasco RRl. Manifestaciones Orales de la Infección por COVID-19. Int. J. Odontostomat. 2020;14(4):555560.https://dx.doi.org/10.4067/S0718-381X2020000400555
  13. Carreras CM, Amaro J, López AF, Jané E, Somacarrera ML. Oral vesiculobullous lesions associated with SARS-CoV-2 infection.Oral Dis. 2021;3:710-712. https://doi:10.1111/odi.13382
  14. Parra EA, Bermúdez M, Peña CP, Rueda A. Manifestaciones orales y maxilofaciales asociadas a la COVID-19. Revisión de la literatura.Acta Odontol Colomb. 2020;10(Supl.COVID–19):60–80. https://doi.org/10.15446/aoc.v10n3.89447
  15. Halepas S, Lee KC, Myers A, Yoon RK, Chung W, Peters SM. Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients. J Am Dent Assoc. 2021;152(3):202-208. https://doi:10.1016/j.adaj.2020.11.014.
  16. Martínez Chamorro M, Onoda M, Grupo de Patología Infecciosa de la AEPap. Pruebas diagnósticas de laboratorio de COVID-19 [Internet]. Asociación Española de Pediatría de Atención Primaria; 2020 (Citado 2020). Disponible en: https://aepap.org/grupos/grupo-de-Patologiainfecciosa/contenido/documentos-del-gpi.
  17. Saavedra Trujillo CH. Consenso colombiano de atención, diagnóstico y manejo de la infección por SAR-COV-2/COVID-19 en establecimientos de atención de la salud: recomendaciones basadas en consenso de expertos e informadas en la evidencia ACIN-IETS, sección VII población pediátrica. Infectio. 2020;24(3) Supl 2. https://doi.org/10.22354/in.v24i3.851
  18. Asociación Española de Pediatría. Documento de manejo clínico del paciente pediátrico con infección por SARS- CoV-2. Extracto del Documento de manejo clínico del Ministerio de Sanidad.Asociación Española de Pediatría; 2020.
Sistema OJS 3.4.0.5 - Metabiblioteca |